• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

QLT:CN

6.5100 CAD 0.1100 1.72%

As of 15:35:14 ET on 04/17/2014.

Snapshot for QLT Inc (QLT)

Open: 6.4800 Day's Range: 6.4700 - 6.5500 Volume: 2,600
Previous Close: 6.4000 52wk Range: 3.8300 - 7.9000 1-Yr Rtn: +43.75%

Stock Chart for QLT

No chart data available.
  • QLT:CN 6.4950
  • 1D
  • 1M
  • 1Y
6.4000
Interactive QLT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QLT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.5140
Est. EPS (USD) (12/2014) -0.5000
Est. PEG Ratio -
Market Cap (M CAD) 332.54
Shares Outstanding (M) 51.08
30 Day Average Volume 4,888
Price/Book (mrq) 1.9149
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 3.9153
Dividend Ex-Date 06/28/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QLT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QLT

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Jason M AryehChairmanSukhi JagpalChief Financial Officer
Alexander R LussowSenior VP:Business DevelopmentLinda M LupiniSenior VP:Human Resources
More Company Profile & Key Executives for QLT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil